Call: +(263�4) 620181-7 | Contact Us
Varichem Pharmaceuticals is a wholly Zimbabwean, privately owned company established in 1985. Varichem manufactures and markets a wide range of quality generic pharmaceuticals and related products.
Varichem was born in 1985 out of the awareness of the acute, sometimes critical, need for reliable cost effective health care products often seriously lacking in the delivery of medical care in Zimbabwe, a country which had been dominated by the heavy weight pharmaceutical multinationals. The entrance of Varichem into the health care business signaled a new era in the whole pharmaceutical market by changing the rules of the game.
In 2010 Varichem became the first wholly indigenous African company to attain World Health Organization (WHO) prequalification. With the WHO prequalification it means we have attained WHO quality standards for our manufacturing plant. Two of our ARVs,which are Stalanev 30 (Stavudine 30mg, Nevirapine 200mg, Lamivudine 150mg) and Varivar (Lamivudine 150mg, Zidovudine 300mg), have also been prequalified.
To be the preferred entity for our customers and other stakeholders as we touch lives through the provision of quality healthcare products and solutions in Africa and beyond.
To create sustainable value through the provision of cost effective healthcare products to meet current and future demands of the customers and expectations of our stakeholders.
Committed to cost effective healthcare.
Corporate social investment is one of the cornerstones of the business philosophy of Varichem. Our focus is to identify worthwhile community needs - particularly those associated with our core business, health care and to mobilize product, finance and human resources to help meet those needs, where appropriate. The process is not only an integral part of our operating culture but also represents our investment in the society in which we operate- a society on which we ultimately depend for our growth and success. Above all, it reflects our belief that business has a key role to play in helping societies cope with the increasing social challenges.
We endeavor to carry out our operations in an environment friendly manner, which results in the minimum possible damage to nature. Varichem recognizes the importance of ensuring the provision of a safe and healthy environment both within and outside the company. The protection of the environment is critical to the long- term sustainable future of the country and its citizens.
From the very beginning, we got encouraging support from both the public and private sectors and our presence on the domestic market has largely contributed to the availability of affordable, quality and efficacious medicines.
Besides fulfilling local demand, we have established very good business relationships with regional buyers. Now we are exporting our generic pharmaceuticals to Malawi, Botswana, South Africa, Namibia, Lesotho and Swaziland. From a humble export figure, our exports have increased many folds over the past five years and this indicates growing confidence of our regional customers on our products.
Varichem is committed to increasing shareholders� wealth through the application of innovative processes, value added customer services and exploitation of first mover advantage in the development and marketing of patent and imminent patent expiry pharmaceuticals.
We afford our current and prospective employees equal employment opportunities with due recognition being give to skill, ability and performance. The company creates a conducive working environment with proper training programs to enable employees to adequately perform their duties. We offer competitive remuneration so as to retain our human capital.
To enable the company achieve excellent customers service and increase shareholders� wealth, Varichem affords its suppliers equal opportunities and above all, establish working relationships on the basis of mutual benefaction, in order to realize its strategic intent.